|
KDM4C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.880300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.670500E-02 |
| Normal-vs-Stage2 |
9.048200E-02 |
| Normal-vs-Stage3 |
3.137800E-02 |
| Normal-vs-Stage4 |
6.063500E-02 |
| Stage1-vs-Stage2 |
9.976400E-01 |
| Stage1-vs-Stage3 |
5.636600E-01 |
| Stage1-vs-Stage4 |
6.149800E-01 |
| Stage2-vs-Stage3 |
6.320200E-01 |
| Stage2-vs-Stage4 |
5.868600E-01 |
| Stage3-vs-Stage4 |
9.004200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.202100E-02 |
| Normal-vs-AfricanAmerican |
1.463010E-01 |
| Normal-vs-Asian |
3.519000E-01 |
| Caucasian-vs-AfricanAmerican |
6.420800E-01 |
| Caucasian-vs-Asian |
8.947800E-01 |
| AfricanAmerican-vs-Asian |
9.744800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.703700E-02 |
| Normal-vs-Female |
3.147400E-01 |
| Male-vs-Female |
1.631370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.320000E-02 |
| Normal-vs-Extreme_Weight |
3.584200E-02 |
| Normal-vs-Obese |
2.414800E-01 |
| Normal-vs-Extreme_Obese |
4.906300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.298000E-01 |
| Normal_Weight-vs-Obese |
4.870800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.661400E-01 |
| Extreme_Weight-vs-Obese |
2.657200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.124800E-01 |
| Obese-vs-Extreme_Obese |
3.431400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.113800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.989600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.330100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.985530E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.929400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.746000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.090400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.173600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.579210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.410400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.297800E-02 |
| Normal-VS-Type2 PRCC |
4.261300E-03 |
| Normal-VS-KIRP CIMP |
3.352400E-01 |
| Normal-VS-Unclassified PRCC |
2.569600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.453900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.662000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.562200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.023800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.219220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.068600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.060620E-03 |
| Normal-vs-N1 |
2.470200E-02 |
| Normal-vs-N2 |
1.664570E-01 |
| N0-vs-N1 |
8.276800E-01 |
| N0-vs-N2 |
9.820200E-01 |
| N1-vs-N2 |
9.190600E-01 |
|
|
